Deals
Charterhouse eyes possible $1.1 billion sale of UK medical company Tunstall
British private equity firm Charterhouse [CHCAP.UL] is working with JP Morgan (JPM.N) on options for healthcare company Tunstall, in a deal which could value the company at up to 700 million pounds ($1.1 billion), a source familiar with the matter said on Tuesday.
Lone Star Funds to buy Home Properties for $7.6 billion, including debt
Private equity firm Lone Star Funds said it had agreed to buy real estate investment trust (REIT) Home Properties Inc (HME.N) for about $7.6 billion, including debt.
ETE confirms $48 billion bid for reluctant Williams Co
Energy Transfer Equity LP confirmed it had made a $48 billion unsolicited bid for natural gas pipeline company Williams Companies Inc, hours after Williams rejected the offer as significantly too low.
CVC and Temasek to buy $2 billion generic drugs firm Alvogen
European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.




